Neuland Laboratories enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


24,117	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
76.7	76.7	240	87.6	45.4
197	197	136	82.5	122
24,237	—	—	—	—
120	120	−104	−5.1	76.1
₹18,787.98	—	—	—	—

2,071	2,071	1,661	1,365	1,116
9.5%	9.5%	8.2%	6.0%	10.9%
0.01×	—	—	—	—

10.22×	—	—	—	—
31.77×	—	—	—	—
36.46×	—	—	—	—
2,372	2,023	1,477	1,559	1,191
763	574	323	463	272
665	483	258	403	219
—	347	317	261	237
−49.4	−49.4	111	118	171
—	−53.7	109	114	168
—	396	206	144	66.1

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NEULANDLAB₹18,695.00

Neuland Laboratories Ltd.

· Pharma & Health

₹ CrorePeersDIVISLAB LAURUSLABS NH NATCOPHARM LALPATHLAB SAILIFE COHANCE ASTERDMMcap ₹24,117 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	24,117.5
- Cash, Equiv & ST Investments	45.4	87.6	239.6	76.7	76.7
+ Total Debt	121.5	82.5	136.0	196.6	196.6
Enterprise Value	—	—	—	—	24,237.4
Net Debt (memo)	76.1	-5.1	-103.6	119.9	119.9
EV per Share	—	—	—	—	18,787.98

Total Capital	1,115.6	1,365.2	1,660.8	2,071.1	2,071.1
Total Debt/Total Capital	10.89	6.04	8.19	9.49	9.49
Total Debt/EV	—	—	—	—	0.01

EV/Sales	—	—	—	—	10.22
EV/EBITDA	—	—	—	—	31.77
EV/EBIT	—	—	—	—	36.46
Reference Items — Trailing FY Values
Sales	1,191.2	1,558.6	1,476.8	2,023.0	2,371.8
EBITDA	271.8	462.6	323.3	574.5	762.9
EBIT	219.1	402.9	257.7	482.8	664.8
Operating Cash Flow	237.2	261.2	317.4	346.7	—
Free Cash Flow	171.1	117.5	110.9	-49.4	-49.4
FCFF (free cash flow to the firm)	168.1	114.1	109.2	-53.7	—
Capital Expenditure	66.1	143.7	206.5	396.0	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.